Form 4: UNITED THERAPEUTICS Director Reports Stock Transaction
Insider Transaction (Form 4)
Ray Kurzweil, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 9, 2026.
Summary
- Option exercise/conversion: acquired 650 Common Stock on July 9, 2026; holds 13,320 after (Direct).
- Option exercise/conversion: disposed of 650 Restricted Stock Units on July 9, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ray Kurzweil — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Option exercise/conversion | Common Stock | 650 | — | — | 13,320 |
| 2026-07-09 | Option exercise/conversion | Restricted Stock Units | 650 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Option exercise/conversion (650 shares) |
| 2026-07-09 | Option exercise/conversion (650 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, neutral, Ray Kurzweil
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.